Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?

Affiliations

• ¹ Clinical Investigation Centre Biotherapy INSERM CIC-1431, University Hospital of Besançon, Besançon, France; Fédération Hospitalo-Universitaire INCREASE, University Hospital of Besançon, Besançon, France; Department of Rheumatology, University Hospital of Besançon, Besançon, France; Department of Therapeutics and UPRES EA 4266 « Agents Pathogènes et Inflammation», University of Bourgogne Franche-Comté, Besançon, France.
• ² Paris-Descartes University, Paris, France; Department of Internal Medicine, Centre de référence maladies auto-immunes et systémiques rares, Hôpital Cochin, AP-HP, Paris, France.
• ³ Department of Rheumatology , University Hospital of Brest , Brest , France.
• ⁴ Department of Internal Medicine , Centre de référence maladies auto-immunes et systémiques rares, Hôpital Cochin, AP-HP , Paris , France.